Different schemes of B-cell chronic lymphocytic leukaemia (B-CLL) treatment in the population affected by the Chernobyl accident

✍ Scribed by Oksana M. Polyshchuk; Iryna S. Dyagil; Viktor I. Klymenko; Dimitry A. Bazyka; Iryna A. Kryachok

• Publisher: Wielkopolskie Centrum Onkologii
• Year: 2005
• Tongue: Polish
• Weight: 121 KB
• Volume: 10
• Category: Article
• ISSN: 1507-1367
• DOI: 10.1016/s1507-1367(05)71082-8

✦ Synopsis

Background

Remarkable advance in the knowledge of the biology and treatment of chronic lymphocytic leukaemia (CLL) has been noted in recent years. CLL resembles several heterogeneous diseases with variable morphological features. New agents with antileukemic activity have been introduced recently for CLL patients, which improved the treatment results. Fludarabin has shown its effi cacy in CLL both as a treatment of choice and in combination with conventional cytostatic agents. Clinical and haematological features of B-CLL in persons affected by the Chernobyl accident in the last period are presented.